Naoumov N - Search Results

1

Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections.

Meier UC, Owen RE, Taylor E, Worth A, Naoumov N, Willberg C, Tang K, Newton P, Pellegrino P, Williams I, Klenerman P, Borrow P. Meier UC, et al. Among authors: naoumov n. J Virol. 2005 Oct;79(19):12365-74. doi: 10.1128/JVI.79.19.12365-12374.2005. J Virol. 2005. PMID: 16160163 Free PMC article.

2

Protection of hepatocytes from cytotoxic T cell mediated killing by interferon-alpha.

Willberg CB, Ward SM, Clayton RF, Naoumov NV, McCormick C, Proto S, Harris M, Patel AH, Klenerman P. Willberg CB, et al. PLoS One. 2007 Aug 29;2(8):e791. doi: 10.1371/journal.pone.0000791. PLoS One. 2007. PMID: 17726521 Free PMC article.

3

Direct evidence that naturally occurring mutations within hepatitis B core epitope alter CD4+ T-cell reactivity.

Torre F, Cramp M, Owsianka A, Dornan E, Marsden H, Carman W, Williams R, Naoumov NV. Torre F, et al. J Med Virol. 2004 Mar;72(3):370-6. doi: 10.1002/jmv.20016. J Med Virol. 2004. PMID: 14748060

4

Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus surface antigen and virions.

Schilling R, Ijaz S, Davidoff M, Lee JY, Locarnini S, Williams R, Naoumov NV. Schilling R, et al. J Virol. 2003 Aug;77(16):8882-92. doi: 10.1128/jvi.77.16.8882-8892.2003. J Virol. 2003. PMID: 12885906 Free PMC article.

5

Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy.

Tang KH, Herrmann E, Cooksley H, Tatman N, Chokshi S, Williams R, Zeuzem S, Naoumov NV. Tang KH, et al. Among authors: naoumov nv. J Hepatol. 2005 Nov;43(5):776-82. doi: 10.1016/j.jhep.2005.05.024. Epub 2005 Jun 28. J Hepatol. 2005. PMID: 16139918

6

Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C.

Pham TN, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI. Pham TN, et al. Among authors: naoumov nv. J Virol. 2004 Jun;78(11):5867-74. doi: 10.1128/JVI.78.11.5867-5874.2004. J Virol. 2004. PMID: 15140984 Free PMC article.

7

Specific deletions in the hepatitis B virus core open reading frame in patients with chronic active hepatitis B.

Ackrill AM, Naoumov NV, Eddleston AL, Williams R. Ackrill AM, et al. Among authors: naoumov nv. J Med Virol. 1993 Oct;41(2):165-9. doi: 10.1002/jmv.1890410213. J Med Virol. 1993. PMID: 8283179

8

Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy.

Ijaz S, Arnold C, Dervisevic S, Mechurova J, Tatman N, Tedder RS, Naoumov NV. Ijaz S, et al. Among authors: naoumov nv. J Med Virol. 2008 Jul;80(7):1160-70. doi: 10.1002/jmv.21206. J Med Virol. 2008. PMID: 18461609 Clinical Trial.

9

Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance.

Hou J, Schilling R, Janssen HL, Hansen BE, Heijtink R, Sablon E, Williams R, Lau GK, Schalm SW, Naoumov NV. Hou J, et al. J Med Virol. 2007 Aug;79(8):1055-63. doi: 10.1002/jmv.20935. J Med Virol. 2007. PMID: 17596838

10

Impact of NS5A sequences of Hepatitis C virus genotype 1a on early viral kinetics during treatment with peginterferon- alpha 2a plus ribavirin.

Dal Pero F, Tang KH, Gerotto M, Bortoletto G, Paulon E, Herrmann E, Zeuzem S, Alberti A, Naoumov NV. Dal Pero F, et al. J Infect Dis. 2007 Oct 1;196(7):998-1005. doi: 10.1086/521306. Epub 2007 Aug 21. J Infect Dis. 2007. PMID: 17763320 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters